Scientific Publications

Gieseler RK, Marquitan G, Schlattjan M, Sowa J-P, Bechmann LP, Timm J, Roggendorf M, Gerken G, Friedman SL, Canbay A. Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. J Viral Hepatol 2010: In Press. Bechmann LP, Jochum C, Kocabayoglu P, Kassalik M, Gieseler RK, Saner F, Paul A, Gerken G, Canbay A, Cytokeratin 18-based Modification of the MELD Score Improves Prediction of Spontaneous Survival after Acute Liver Injury. J Hepatol 2010: In Press.
	Associated Editorial: Samuel D, Ichai P. Prognosis indicator in acute liver failure: Is there a place for cell death markers? J Hepatol 2010: In Press.
Dechêne A, Sowa J-P, Gieseler RK, Jochum C, Bechmann L, El Fouly A, Schlattjan M, Saner F, Baba H, Paul A, Dries V, Gerken G, Friedman SL, Canbay A. Acute Liver Failure is Associated with Elevated Liver Stiffness and Hepatic Stellate Cell Activation. Hepatology 2010, May 14: Epub. Link Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I, Emons B, Jochum C, Feldkamp T, Gerken G, Canbay A. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis. Liver Int 2010, April 9: Epub. Link Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 2010;51:92-102. Link
	Associated Editorial: Gao B. Natural killer group 2 member D, its ligands, and liver disease: good or bad? Hepatology 2010;51:8-11. Link
Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH, Roggendorf M, Gerken G, Canbay A. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 2009;80:235-40. Link